At therapeutic IV doses (often 2550 g in oncology and critical-care research), studies report improvements in inflammation markers, oxidative stress, and quality of life in advanced cancer and sepsis, although evidence is strongest for adjunctive rather than standalone use
Y lo ms llamativo: en algunos casos especialmente con la L-carnitina , se produjo un fenmeno conocido como estrs reductivo : un exceso de antioxidantes que alter el equilibrio interno del organismo
7h, i and Supplementary Fig
Lower-end ranges (20-40 mcg/day) are most commonly cited for tolerance assessment and women's protocols
[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Eng J, Kleinman WA, Singh L, Singh G, Raufman JP
Then a landmark clinical trial enrolled thousands of patients with high-risk breast cancer, gave them either metformin or a placebo alongside standard treatment, and followed them for five years